Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy.
Publication/Presentation Date
12-1-2022
Abstract
Circulating Angiogenic Factor in Hypertension in PregnancyThis study measured serum soluble fms-like tyrosine kinase 1 to placental growth factor values in pregnant women hospitalized with hypertension. In women with a hypertensive disorder of pregnancy presenting between 23 and 35 weeks' gestation, a soluble fms-like tyrosine kinase 1:placental growth factor ratio ≥40 provided stratification of the risk of progressing to severe preeclampsia within 2 weeks.
Volume
1
Issue
12
First Page
2200161
Last Page
2200161
ISSN
2766-5526
Published In/Presented At
Thadhani, R., Lemoine, E., Rana, S., Costantine, M. M., Calsavara, V. F., Boggess, K., Wylie, B. J., Moore Simas, T. A., Louis, J. M., Espinoza, J., Gaw, S. L., Murtha, A., Wiegand, S., Gollin, Y., Singh, D., Silver, R. M., Durie, D. E., Panda, B., Norwitz, E. R., Burd, I., … Kilpatrick, S. (2022). Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM evidence, 1(12), EVIDoa2200161. https://doi.org/10.1056/EVIDoa2200161
Disciplines
Medicine and Health Sciences
PubMedID
38319832
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article